NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Generics


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
AHRQ News and Numbers: AHRQ Spends Nearly $20 Billion on Blood Thinners for Adults
2009 NOV 23 ... out-of-pocket payment for a brand name blood thinner was $65 and $29, respectively, and generics were $18 and $7, respectively. AHRQ also found that: About 10 ...
Subject: Coagulation
Price: $3.00
*
Asia Pacific Pharma Sector Analysis - the Industry is Projected to Grow at a CAGR of around 12.6% During 2010-2012
2009 NOV 23 ... seen significant developments in the field of contract manufacturing, particularly in generics and APIs. Several technological advancements have also boosted the R&D activities in the ...
Subject: Research and Markets
Price: $3.00
*
Cambridge Regulatory Services forge strategic alliance with SIRO Clinpharm
2009 NOV 16 ... medicines, including new small molecule or biotech entities, Biologics, Herbals and Generics. Services include preparing Clinical Trial Applications, Marketing Authorisation ...
Subject: Business News
Price: $3.00
*
CVS Caremark Reports Record Third Quarter 2009 Results
2009 NOV 16 ... billion in the third quarter of 2009. Adjusting the growth rate for the impact of new generics, net revenues would have grown 27.2% in the pharmacy services segment. Pharmacy network ...
Subject: CVS Caremark Corporation
Price: $3.00
*
Impax Laboratories Confirms Patent Challenge Relating to TRICOR(R) 48mg and 145mg Tablets
2009 NOV 16 ... and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products ...
Subject: Impax Laboratories, Inc.
Price: $3.00
*
Impax Laboratories to Present at the Credit Suisse 18th Annual Healthcare Conference
2009 NOV 23 ... and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products ...
Subject: Impax Laboratories, Inc.
Price: $3.00
*
In 2013, the Global Generics Market Is Forecast To Have a Value of $292 Billion, an Increase of 52.2% Since 2008
2009 NOV 24 ... has announced the addition of the "Generics: Global Industry Guide" report to their offering....
Subject: Research and Markets
Price: $3.00
*
Latest Report for the United States Pharmaceuticals and Healthcare Industry as We Find out Healthcare Spending in 2008 Reached US$2.3 Trillion
2009 NOV 23 ... can be troublesome. The possible ban of pay-to-delay settlements and authorised generics could also provide a major downside for patented drugs. The shape of economic recovery ...
Subject: Research and Markets
Price: $3.00
*
Mylan Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories
2009 NOV 23 ... visit www.mylan.com. Keywords: Biotechnology, Drug Development, Drugs, FDA, Generics, Lansoprazole, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, ...
Subject: Generics
Price: $3.00
*
Mylan's Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier
2009 NOV 23 ... its subsidiary Mylan SA has received the prestigious 2009 Elsevier Galien Award for Best Generics Company in Spain. The award recognizes the company's outstanding development in the ...
Subject: Mylan Inc.
Price: $3.00
*
Per Capita Expenditure on the Netherlands Pharmaceutical Products Is Considerably Lower Than Nearby Belgium, France or Germany at US$573 In 2009
2009 NOV 23 ... Drugs Chronic Ailment Repeat Prescriptions Increase Generics Sector OTC Sector Projections & Outlook Imports ...
Subject: Research and Markets
Price: $3.00
*
Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
2009 NOV 16 ... Nervous System Agent, Drugs, Ergocalciferol, Fexofenadine, Fexofenadine Hydrochloride, Generics, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Pseudoephedrine, ...
Subject: Generics
Price: $3.00
*
Reports from Tilburg University advance knowledge in generics Generics
2009 NOV 23 ... Keywords: Netherlands, Tilburg, Abilify, Antipsychotic, Aripiprazole, Drugs, Generics, Mental Health, Olanzapine, Pharmaceuticals, Psychiatry, Psychotic Disorder, Quetiapine, ...
Subject: Generics
View Free
Daily News
Article
South Africa Pharma to Post Strong Growth in Future
2009 NOV 16 ... several different segments of pharma market in this region and found that at present, generics is growing faster than branded drugs and in future, this trend is also expected to ...
Subject: Pharmaceuticals
Price: $3.00
*
Teva Receives Final Approval for Generic Prevacid(R) Delayed-Release Capsules
2009 NOV 23 ... Ecology, Environment, Food, Insurance, Biotechnology, Drug Development, Drugs, Generics, Lansoprazole, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, ...
Subject: Teva Pharmaceutical Industries Ltd.
Price: $3.00
*
The Outlook for Pharmaceuticals in Central Asia - Bangladesh Pharmaceutical Exports Are Expected To Increase by 20%-25% by the End of 2008
2009 NOV 23 ... Tianjin. The Chinese pharmaceutical industry tends to focus on the manufacture of cheap generics and copycat drugs and counterfeiting remains a problem. Imports of pharmaceuticals, ...
Subject: Research and Markets
Price: $3.00
*
This Essential Q4 2009 South Africa Pharmaceuticals and Healthcare Report Provides Independent Forecasts and Competitive Intelligence on the Industry
2009 NOV 16 ... chiefly by ongoing strikes by doctors and nurses in the public sector. Generics will account for 30% of the total drug market, and 36% of the total prescription market. ...
Subject: Research and Markets
Price: $3.00
*
Wound Treatments in the Netherlands: a Comprehensive Guide To the Size and Shape of the Market At a National Level
2009 NOV 24 ... EU Legislation Self-medication and Preventative Medicine Generics Keywords: Research and Markets, Health, Other Health, Sports, Advertising, ...
Subject: Research and Markets
Price: $3.00
*
ZS Associates Opens Spain Office
2009 NOV 23 ... enjoyed unprecedented growth in recent years, but patent expirations, increased use of generics and the impact of the economy on regional health care budgets is forcing them to ...
Subject: Pharmaceuticals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login